David Littler, the UK General Manager at enChoice UK, discusses how AI-powered search is transforming content repositories within organisations, thereby improving user access to information.
José Bastos, Director at knok, explores how data from remote diagnosis will alter healthcare and discusses how knok will play its part in this digital transformation journey.
Jeremy Wyatt, Operations Director at Fantastic Cloud Services Limited, explores some of the most commonly encountered issues organisations face when it comes to Backup and Disaster Recovery.
Here, Coordinator of the Intelligent Management Systems for Integrated Multi-Trophic Aquaculture (IMPAQT) project Frank Kane discusses the path to revolutionising aquaculture and increasing the industry’s sustainability.
Karen Steel at Granicus discusses how local government communications could significantly help to stop the spread of COVID misinformation, especially when it comes to vaccinations.
According to radiologists at Massachusetts General Hospital (MGH), swollen lymph nodes after COVID vaccination are a "normal reaction that typically goes away with time".
A Northwestern Medicine study used Artificial Intelligence to analyse tweets and figure out how COVID misinformation on social media can erase scientific truths from public awareness.
Researchers at Yale believe that blood tests could predict severe or critical COVID cases, because blood holds a series of interesting biological signals about a person.
Israel faced international criticism on their refusal to vaccine Palestinians - now, the country will begin rolling out Pfizer shots to some Palestinians who have work permits.
New data suggests that before 60 days of COVID symptoms beginning is the best window for convalescent plasma donation - which is how antibodies were created in countless COVID-19 patients before vaccines.
Israel is currently leading the world in COVID vaccination, with real-world data to suggest that the Pfizer vaccine is working to stop 92% of severe COVID cases.
New data from the REACT study finds that 14% of the UK population have antibodies against COVID-19 now, but that vaccine hesitancy is currently highest in London.
